Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial

ISRCTN ISRCTN94738550
DOI https://doi.org/10.1186/ISRCTN94738550
ClinicalTrials.gov number NCT00528658
Secondary identifying numbers HKCEM06-07/DG2041095
Submission date
06/09/2007
Registration date
19/10/2007
Last edited
15/07/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Colin Graham
Scientific

Trauma and Emergency Centre
Prince of Wales Hospital
Shatin
NT
Hong Kong

Study information

Study designProspective, double-blind, randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleCost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial
Study hypothesisWe hypothesise firstly that paracetamol 1 g and ibuprofen 400 mg administered orally for soft tissue injuries have equal analgesic efficacy; secondly that paracetamol has less adverse effects than ibuprofen; and that when all additional health care related costs are taken into account, that paracetamol will be the more cost-effective option.
Ethics approval(s)Ethics approval received from the Joint Chinese University of Hong Kong - New Territories East Cluster (CUHK-NTEC) Clinical Research Ethics Committee on the 8th October 2004 (ref: CRE-2004.266-T).
ConditionSoft Tissue Injuries
InterventionArm 1: Paracetamol 1 g four times daily (qid) and ibuprofen placebo equivalent to 400 mg three times daily (tid)
Arm 2: Paracetamol placebo equivalent to 1 g qid and ibuprofen 400 mg tid
Arm 3: Paracetamol 1 g qid and ibuprofen 400 mg tid

Treatment will continue for three days, follow-up will continue for 30 days.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Paracetamol, ibuprofen
Primary outcome measureAnalgesic efficacy both at rest and with movement at 72 hours.
Secondary outcome measures1. Presence, frequency and duration of adverse effects at 30 days
2. Cost-effectiveness analysis at 30 days
3. Patient satisfaction with analgesia at 30 days
Overall study start date01/01/2005
Overall study end date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants783
Total final enrolment782
Participant inclusion criteriaAll patients greater than 16 years presenting to the Emergency Department (ED) with isolated soft tissue injury without significant fracture between 9 am to 5 pm, Monday to Friday.
Participant exclusion criteriaPatients will be excluded if there is:
1. A history of peptic ulceration or haemorrhage
2. Recent anticoagulation
3. Pregnancy
4. Adverse reaction to paracetamol or ibuprofen
5. Renal or cardiac failure
6. Hepatic problems
7. Rectal bleeding
8. Chronic Non-Steriodal Anti-Inflammatory Drug (NSAID) consumption
9. Asthma
10. Chronic obstructive pulmonary disease
11. Chronic pain syndromes
12. Prior treatment with analgesia for the same injury

Patients will also be excluded if they have a physical, visual or cognitive impairment making use of the visual analogue scale unreliable.
Recruitment start date01/01/2005
Recruitment end date31/12/2007

Locations

Countries of recruitment

  • Hong Kong

Study participating centre

Trauma and Emergency Centre
Shatin
NT
Hong Kong

Sponsor information

Chinese University of Hong Kong (Hong Kong)
University/education

Trauma and Emergency Centre
Prince of Wales Hospital
Shatin
NT
Hong Kong

Website http://www.cuhk.edu.hk
ROR logo "ROR" https://ror.org/00t33hh48

Funders

Funder type

University/education

Chinese University of Hong Kong (Hong Kong) (Direct Grant: 2041095)

No information available

Hong Kong College of Emergency Medicine (Hong Kong) (Grant: 2006-07)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 06/02/2018 15/07/2021 Yes No

Editorial Notes

15/07/2021: ClinicalTrials.gov number, total final enrolment and publication reference added.